ANDA 74543, held by Sentiss. Albuterol Sulfate.
As of Nov 18, 2026, ANDA 74543 (Albuterol Sulfate), held by Sentiss, was first approved by FDA on Jan 15, 1998, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 15, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 0.5% BASE · solution;inhalation | Albuterol Sulfate | Rx |
| Mar 31, 2017 | Supplement 7Labeling · Standard review | Approved | None posted |
| Apr 30, 2010 | Supplement 4Labeling | Approved | None posted |
| Aug 31, 2009 | Supplement 3Labeling | Approved | None posted |
| Jan 15, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters